FDA: Manufacturers Not Making Progress In Improving Recall Notifications
This article was originally published in The Silver Sheet
Executive Summary
MANUFACTURER RECALL NOTIFICATIONS LACK SPECIFIC INFORMATION that could help customers, FDA says. Too often, recall letters "are soft-pedaled or there's clearly not adequate information about risk," says Cap Uldriks, CDRH associate director for regulatory guidance and government affairs. A recent review by TJR Consulting Services of 20 random device-related recall letters found that many firms fail to include basic information, including the classification of the recall, manufacturer contacts and information on possible adverse effects. "Almost all of the recall notices that I get truly are incomplete," says Bea Haupt, recall & safety manager for Inova Health System, who says she wants "to see all three of these in a recall notice: the adverse effects statement, information on whether the government has knowledge of the recall, and the potential hazards." Also in this issue, Medtronic and Cordis officials explain their approaches to recall notices
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.